178 related articles for article (PubMed ID: 27840980)
1. Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
Oncol Rep; 2017 Jan; 37(1):163-170. PubMed ID: 27840980
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.
Huang HL; Hsu HP; Shieh SC; Chang YS; Chen WC; Cho CY; Teng CF; Su IJ; Hung WC; Lai MD
Mol Cancer Ther; 2013 Nov; 12(11):2505-16. PubMed ID: 23979921
[TBL] [Abstract][Full Text] [Related]
3. Argininosuccinate lyase is a potential therapeutic target in breast cancer.
Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
Oncol Rep; 2015 Dec; 34(6):3131-9. PubMed ID: 26397737
[TBL] [Abstract][Full Text] [Related]
4. Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.
Hung YH; Huang HL; Chen WC; Yen MC; Cho CY; Weng TY; Wang CY; Chen YL; Chen LT; Lai MD
Oncol Rep; 2017 Feb; 37(2):969-978. PubMed ID: 28035420
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells.
Sheng N; Yan L; You W; Tan G; Gong J; Chen H; Yang Y; Hu L; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):926-934. PubMed ID: 28981607
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
8. [Expression of PSF1 in colon cancer tissues and its effect on the proliferation of colon cancer cells].
Wen JZ; Han XY; Wei B; Zhang S; Wei HB
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):70-4. PubMed ID: 23355245
[TBL] [Abstract][Full Text] [Related]
9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
10. [The effects of lentivirus-mediated RNA interference silencing HMGA2 on proliferation and expressions of cyclin B2 and cyclin A2 in HL-60 cells].
Liu WD; Tan L; Xiong XF; Liang YP; Tan H
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):448-52. PubMed ID: 22967378
[TBL] [Abstract][Full Text] [Related]
11. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Smad4 enhances proliferation and invasion of colorectal carcinoma HCT116 cells and up-regulates Id2.
Shi Q; Zhong YS; Yao LQ; Li QL; Ren Z; Liu XP; Shi FM
Mol Med Rep; 2012 Jan; 5(1):89-95. PubMed ID: 21956276
[TBL] [Abstract][Full Text] [Related]
16. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancer.
Lv W; Zhang C; Zhou DH; Hao J; Sun JG; Liu T; Hao YX; Yu PW
Cancer Biother Radiopharm; 2007 Dec; 22(6):841-52. PubMed ID: 18158776
[TBL] [Abstract][Full Text] [Related]
18. Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer.
Wahab R; Gopalan V; Islam F; Smith RA; Qiao B; Lam AK
Eur J Cell Biol; 2017 Sep; 96(6):487-495. PubMed ID: 28764863
[TBL] [Abstract][Full Text] [Related]
19. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
